Ascletis Pharma Inc.

Direct answer

Ascletis Pharma Inc. is publicly traded on HKSE under the ticker 1672.HK.

Ascletis Pharma Inc. is a biotechnology firm engaged in the discovery, development, manufacturing, marketing, and global distribution of pharmaceutical products, with operations spanning Mainland China and international markets. The company's commercialized offerings include the Ritonavir oral tablet, a pharmacokinetic enhancer for various oral antiviral drugs targeting viral proteases and a key component of the...

Can you invest in Ascletis Pharma Inc.?

Yes. Ascletis Pharma Inc. is publicly traded on HKSE under the ticker 1672.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Ascletis Pharma Inc.

Detailed equity research is provided by MarketSnap.